Clinical Trial Update: Nasal Antisepsis for C. Auris Prevention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating nasal antisepsis to prevent Candida auris infection and colonization is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Auris Colonization
• Candida Auris Infection

Snippet

Sponsor: Mary K Hayden | Conditions: Candida Auris Infection, Colonization, Asymptomatic | Phase 4 | Status: RECRUITING